Alimera Sciences, Inc.

DGAP-News: Alimera Sciences Announces Positive Outcome to the European Decentralized Procedure for Approval of ILUVIEN(R) for the Treatment of Chronic Diabetic Macular Edema

Alimera Sciences, Inc. 28.02.2012 12:30 --------------------------------------------------------------------------- -- ILUVIEN(r) expected to be the first sustained release pharmaceutical in the European Union to treat diabetic macular edema (DME) -- ILUVIEN expected to be indicated for ...

28.02.2012 | Wirtschaft (allg.)